Trials / Sponsors / Orinove, Inc.
Orinove, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-02-09 |
| Completed | Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Effect of Drug | Phase 1 / Phase 2 | 2020-07-01 |
| Completed | ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer Advanced Solid Tumor, Metastatic Breast Cancer | Phase 1 / Phase 2 | 2019-05-25 |